Clinical trial

The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary…

NCT00217269 · Medtronic Vascular, Industry · Completed

Key facts

NCT number NCT00217269
Title The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions
Official title A Randomized, Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions
Acronym ENDEAVOR IV
Lead sponsor Medtronic Vascular, Industry
Status Completed
Study type Interventional
Conditions Coronary Artery Disease
Intervention type Device
Interventions Coronary Artery Stenting
Enrollment 1,548
Start date Apr 1, 2005
Primary completion Mar 1, 2007
Completion Jul 1, 2011
First posted Sep 22, 2005
Last update posted Apr 20, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies